{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:53:09Z","timestamp":1778788389344,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/312\/45"],"award-info":[{"award-number":["RGP2\/312\/45"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/302\/44"],"award-info":[{"award-number":["RGP2\/302\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.tice.2024.102416","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T18:08:28Z","timestamp":1716487708000},"page":"102416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of tissue biomarkers between non-schistosoma and schistosoma-associated urothelial carcinoma"],"prefix":"10.1016","volume":"88","author":[{"given":"Nashwah Samir","family":"AlHariry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas A.","family":"El Saftawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma Emad","family":"Aboulhoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed H.","family":"Abozamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany E.","family":"Hamoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa Abd Elgawad","family":"Khalil Ghanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2024.102416_bib1","article-title":"Uncovering the epidemiology of bladder cancer in the Arab world: A review of risk factors, molecular mechanisms, and clinical features","author":"Abbas","year":"2023","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.tice.2024.102416_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.pharep.2018.02.016","article-title":"S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11and TNF-\u03b1 in mice","volume":"70","author":"Abdi","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.tice.2024.102416_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1017\/S0025727300022237","article-title":"Schistosomiasis in antiquity","volume":"20","author":"Adamson","year":"1976","journal-title":"Med Hist."},{"key":"10.1016\/j.tice.2024.102416_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13104-018-3355-0","article-title":"Under diagnosis of intestinal schistosomiasis in a referral hospital, North Ethiopia","volume":"11","author":"Alemu","year":"2018","journal-title":"BMC Res Notes"},{"issue":"6","key":"10.1016\/j.tice.2024.102416_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr938","article-title":"The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer","volume":"6","author":"Allred","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.tice.2024.102416_bib6","article-title":"High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy","volume":"Vol. 39","author":"Amano","year":"2021"},{"issue":"4","key":"10.1016\/j.tice.2024.102416_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12253-010-9263-9","article-title":"Estrogen receptor alpha polymorphisms and the risk of malignancies","volume":"16","author":"Anghel","year":"2010","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.tice.2024.102416_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103811","article-title":"A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy","volume":"99","author":"Ayati","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.tice.2024.102416_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000447140","article-title":"Expression of epidermal growth factor receptor and transforming growth factor alpha in Cancer bladder: Schistosomal and non-Schistosomal","volume":"9","author":"Badawy","year":"2015","journal-title":"Curr. Urol."},{"issue":"5","key":"10.1016\/j.tice.2024.102416_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jare.2013.01.005","article-title":"Human schistosomiasis: clinical perspective: review","volume":"4","author":"Barsoum","year":"2013","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.tice.2024.102416_bib11","first-page":"738","article-title":"Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation","volume":"Vol. 38","author":"Bernardo","year":"2020"},{"key":"10.1016\/j.tice.2024.102416_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.eururo.2009.06.032","article-title":"Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder","volume":"56","author":"Bolenz","year":"2009","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.tice.2024.102416_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/aam.aam_48_17","article-title":"A review of bladder cancer in sub-Saharan Africa: a different disease, with a distinct presentation, assessment, and treatment","volume":"17","author":"Bowa","year":"2018","journal-title":"Ann. Afr. Med."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/carcin\/bgaa092","article-title":"Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer","volume":"42","author":"Chatterjee","year":"2021","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.tice.2024.102416_bib15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/JTO.0000000000000500","article-title":"Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC: implication for optional immune targeted therapy for NSCLC patients with EGFR mutation","volume":"10","author":"Chen","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.tice.2024.102416_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/biology10070674","article-title":"Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma","volume":"10","author":"Chiang","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.tice.2024.102416_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00436-009-1483-0","article-title":"Enzymatic antioxidant systems in helminth parasites","volume":"105","author":"Chiumiento","year":"2009","journal-title":"Parasitol. Res."},{"issue":"11","key":"10.1016\/j.tice.2024.102416_bib18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.tice.2024.102416_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5858\/2005-129-194-EREIPU","article-title":"Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma","volume":"129","author":"Croft","year":"2005","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5603\/NJO.2015.0004","article-title":"The influence of environmental risk factors on the development of bladder cancer","volume":"65","author":"D\u0142ugosz","year":"2015","journal-title":"Nowotw. J. Oncol."},{"key":"10.1016\/j.tice.2024.102416_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12639-020-01303-8","article-title":"Validity of urine-CCA cassette test and indirect haem-agglutination assay (IHA) in the detection of schistosomiasis-mansoni infection relative to microscopic examination","volume":"45","author":"El Saftawy","year":"2021","journal-title":"J. Parasit. Dis."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.47665\/tb.39.1.001","article-title":"Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice","volume":"39","author":"El Saftawy","year":"2022","journal-title":"Trop. Biomed."},{"issue":"2","key":"10.1016\/j.tice.2024.102416_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0394632015584733","article-title":"Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment","volume":"28","author":"El-Aal","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"9","key":"10.1016\/j.tice.2024.102416_bib24","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/1078-0432.CCR-17-2210","article-title":"Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell TherapyOvercoming Resistance to Immune ICB","volume":"24","author":"Elia","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"s2","key":"10.1016\/j.tice.2024.102416_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molcel.2015.02.001","article-title":"TNF\u03b1 signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome.","volume":"58","author":"Franco","year":"2015","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.tice.2024.102416_bib27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.it.2021.10.003","article-title":"Unleashing TNF cytotoxicity to enhance cancer immunotherapy","volume":"42","author":"Freeman","year":"2021","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02239-6","article-title":"Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced bladder cancer mouse model","volume":"18","author":"Furuya","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tice.2024.102416_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00262-017-1955-5","article-title":"Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-\u03b1","volume":"66","author":"Hartley","year":"2017","journal-title":"Cancer Immunol., Immunother."},{"key":"10.1016\/j.tice.2024.102416_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0450-3","article-title":"Distinct functions of AKT isoforms in breast cancer: A comprehensive review","volume":"17","author":"Hinz","year":"2019","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib31","first-page":"1","article-title":"Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder","volume":"18","author":"Hussain","year":"2018","journal-title":"BMC Urol."},{"issue":"5","key":"10.1016\/j.tice.2024.102416_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.33594\/000000174","article-title":"EGFR is a therapeutic target in hormone receptor-positive breast cancer","volume":"53","author":"Jeong","year":"2019","journal-title":"Cell Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36922\/td.v1i1.46","article-title":"Advances in the study of the pathogenesis of cancer-related cognitive impairment","volume":"1","author":"Jiang","year":"2022","journal-title":"Tumor Discov."},{"key":"10.1016\/j.tice.2024.102416_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/02841869709001327","article-title":"Cancer patterns in the Middle East. Special report from the Middle East Cancer Society","volume":"36","author":"Kahan","year":"1997","journal-title":"Act. Oncol."},{"issue":"11","key":"10.1016\/j.tice.2024.102416_bib35","first-page":"6779","article-title":"Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder","volume":"34","author":"Klopfer","year":"2014","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.tice.2024.102416_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001119","article-title":"Occurrence of urinary schistosomiasis and associated bacteria in parts of Ondo State, Nigeria","volume":"2","author":"Kone","year":"2022","journal-title":"PLOS Glob. Public Health"},{"issue":"5","key":"10.1016\/j.tice.2024.102416_bib37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.euo.2020.08.013","article-title":"Sex differences in bladder cancer immunobiology and outcomes: a collaborative review with implications for treatment","volume":"3","author":"Koti","year":"2020","journal-title":"Eur. Urol. Oncol."},{"issue":"3","key":"10.1016\/j.tice.2024.102416_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4132\/jptm.2021.02.22","article-title":"Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation","volume":"55","author":"Lee","year":"2021","journal-title":"J. Pathol. Transl. Med."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib39","first-page":"1","article-title":"The inflammatory cytokine TNF-\u03b1 promotes the premature senescence of rat nucleus pulposus cells via the PI3K\/Akt signaling pathway","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2024.102416_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.01.005","article-title":"Interactions between EGFR and PD-1\/PD-L1 pathway: implications for treatment of NSCLC","volume":"418","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"issue":"48","key":"10.1016\/j.tice.2024.102416_bib41","doi-asserted-by":"crossref","first-page":"83986","DOI":"10.18632\/oncotarget.20233","article-title":"Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2024.102416_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153402","article-title":"Protection against chemotherapy-and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals","volume":"80","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cancers13010131","article-title":"Immune checkpoint inhibitors for the treatment of bladder cancer","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2024.102416_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.20510\/pbj\/9\/i2\/1283","article-title":"Assessment of New Protected Mechanism of Liraglutide on CKD Progression","author":"Luaibi","year":"2021","journal-title":"Pharm. Biosci. J."},{"key":"10.1016\/j.tice.2024.102416_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2004.08.012","article-title":"Inhibition of NFD-kappaB in cancer cells converts inflammation induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression","volume":"6","author":"Luo","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0530-3","article-title":"Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-\u03b1-PD-L1 pathway.","volume":"7","author":"Lv","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.tice.2024.102416_bib47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/1535-7163.MCT-18-1194","article-title":"Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model","volume":"18","author":"Berndt-Paetz","year":"2019","journal-title":"Mol. \/\/ Cancer Ther."},{"issue":"2","key":"10.1016\/j.tice.2024.102416_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010\u20132020","volume":"103","author":"Mariotto","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tice.2024.102416_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.steroids.2006.11.019","article-title":"Estrogen receptor signaling pathways in human non-small cell lung cancer","volume":"72","author":"Marquez-Garban","year":"2007","journal-title":"Steroids"},{"issue":"13","key":"10.1016\/j.tice.2024.102416_bib50","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.3390\/ijms22137216","article-title":"Immunological and biochemical interplay between cytokines, oxidative stress and schistosomiasis","volume":"22","author":"Masamba","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102416_bib51","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","article-title":"Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder","volume":"109","author":"Miyamoto","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"WHO Classi\ufb01cation of Tumours of the Urinary System and Male Genital Organs 2014;Part A:Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol. 8222016"},{"key":"10.1016\/j.tice.2024.102416_bib53","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fimmu.2019.01818","article-title":"The TNF paradox in cancer progression and immunotherapy","volume":"10","author":"Montfort","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.juro.2014.07.121","article-title":"The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence","volume":"193","author":"Mooso","year":"2015","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.tice.2024.102416_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.breast.2010.11.004","article-title":"Strength of ER-positivity in relation to survival in ER-positive breast cancer treated by adjuvant tamoxifen as sole systemic therapy","volume":"20","author":"Morgan","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.tice.2024.102416_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-06727-2","article-title":"Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation","volume":"20","author":"Morsch","year":"2020","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.tice.2024.102416_bib57","article-title":"The immunoreactivity of uroplakin III in urothelial carcinoma of urinary bladder and other non-urothelial carcinoma","volume":"19","author":"Naji","year":"2019","journal-title":"Med. Leg. Update"},{"key":"10.1016\/j.tice.2024.102416_bib58","first-page":"833","article-title":"Multidisciplinary biomarkers aggrieve morbidity in schistosomiasis","volume":"36","author":"Noha","year":"2019","journal-title":"Trop. Biomed."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15252\/emmm.201607062","article-title":"After surviving cancer, what about late life effects of the cure?","volume":"9","author":"Nonnekens","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.tice.2024.102416_bib60","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1464-410X.2006.06158.x","article-title":"Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract","volume":"97","author":"Ohtsuka","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.tice.2024.102416_bib61","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.urolonc.2019.02.017","article-title":"Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder","volume":"37","author":"Owyong","year":"2019","journal-title":"Urol. Oncol."},{"issue":"4","key":"10.1016\/j.tice.2024.102416_bib62","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer ImmunotherapyPD-L1 IHC as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tice.2024.102416_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001912","article-title":"Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise","volume":"6","author":"Ray","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tice.2024.102416_bib64","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/PAS.0000000000001264","article-title":"PD-L1 expression in Urothelial carcinoma with predominant or pure variant histology: concordance among 3 commonly used and commercially available antibodies","volume":"43","author":"Reis","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"7_Supplement","key":"10.1016\/j.tice.2024.102416_bib65","first-page":"1929s","article-title":"Inflammation, chromosomal instability, and cancer: the schistosomiasis model","volume":"54","author":"Rosin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2024.102416_bib66","article-title":"Expression of epidermal growth factor receptor and human epidermal growth factor receptor 2 in urothelial bladder carcinoma in an Egyptian cohort: Clinical implication and prognostic significance","author":"Sami","year":"2023","journal-title":"Urol. J."},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib67","first-page":"1","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.tice.2024.102416_bib68","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.1100994108","article-title":"B regulatory cells and the tumor-promoting actions of TNF-\u03b1 during squamous carcinogenesis","volume":"108","author":"Schioppa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.tice.2024.102416_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006134","article-title":"Polypyridylruthenium (II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases","volume":"11","author":"Sundaraneedi","year":"2017","journal-title":"PloS Negl. Trop. Dis."},{"key":"10.1016\/j.tice.2024.102416_bib70","doi-asserted-by":"crossref","first-page":"8315410","DOI":"10.1155\/2018\/8315410","article-title":"Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis","volume":"2018","author":"Szyma\u0144ska","year":"2018","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.tice.2024.102416_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.12.003","article-title":"PD-L1 expression according to the EGFR status in primary lung adenocarcinoma","volume":"116","author":"Takada","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/erc.1.01255","article-title":"Roles of estrogen receptor \u03b1 and \u03b2 in modulating urothelial cell proliferation","volume":"15","author":"Teng","year":"2008","journal-title":"Endocr. -Relat. Cancer"},{"issue":"1","key":"10.1016\/j.tice.2024.102416_bib73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micinf.2008.10.008","article-title":"Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli","volume":"11","author":"Thumbikat","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.tice.2024.102416_bib74","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2018.06.019","article-title":"Frequent PD-L1 protein expression and molecular correlates in urinary bladder squamous cell carcinoma","volume":"74","author":"Udager","year":"2018","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.tice.2024.102416_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/14656566.5.2.263","article-title":"Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control","volume":"5","author":"Utzinger","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.tice.2024.102416_bib76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2019.06.014","article-title":"Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold","volume":"178","author":"Vredevoogd","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tice.2024.102416_bib77","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmb.2009.06.077","article-title":"Uropathogenic E coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction","volume":"392","author":"Wang","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.tice.2024.102416_bib78","first-page":"289","article-title":"Effects of exposure of neonatal mice to 17\u03b2-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia.","volume":"55","author":"Warner","year":"1975","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.tice.2024.102416_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006171","article-title":"The diagnosis and treatment introspection of the first imported case of atypical cerebral schistosomiasis in Guangzhou city","volume":"12","author":"Wei","year":"2018","journal-title":"PloS Negl. Trop. Dis."},{"issue":"11","key":"10.1016\/j.tice.2024.102416_bib80","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2009.73","article-title":"Uroplakins in urothelial biology, function, and disease","volume":"75","author":"Wu","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.tice.2024.102416_bib81","first-page":"1","article-title":"Urinary schistosomiasis and the associated bladder cancer: update","volume":"32","author":"Zaghloul","year":"2020","journal-title":"J. Egypt. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.tice.2024.102416_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059089","article-title":"Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection","volume":"8","author":"Zhong","year":"2013","journal-title":"PloS One"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:36:42Z","timestamp":1777455402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816624001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":82,"alternative-id":["S0040816624001174"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2024.102416","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of tissue biomarkers between non-schistosoma and schistosoma-associated urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2024.102416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102416"}}